Scientific article
OA Policy
English

Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

Published in

RMD open, vol. 8, no. 2, e002726

Publication date

2022-11-02

First online date

2022-11-02

Abstract

Objective : To conduct a systematic literature review (SLR) on the screening and prophylaxis of opportunistic and chronic infections in autoimmune inflammatory rheumatic diseases (AIIRD).

Methods : SLR (inception-12/2021) based on the following search domains: (1) infectious agents, (2) AIIRD, (3) immunosuppressives/immunomodulators used in rheumatology, (4) screening terms and (5) prophylaxis terms. Articles were retrieved having the terms from (1) AND (2) AND (3) plus terms from (4) OR(5). Databases searched: PubMed, Embase and Cochrane Library. Exclusion criteria: studies on postoperative infections, paediatric AIIRD, COVID-19, vaccinations and non-Εnglish literature. Study quality was assessed with Newcastle-Ottawa scale for non-randomised controlled trials (RCTs), RoB-Cochrane for RCTs, AMSTAR2 for SLRs.

Results : From 5641 studies were retrieved, 568 full-text articles were assessed for eligibility, with 194 articles finally included. For tuberculosis, tuberculin skin test (TST) is affected by treatment with glucocorticoids and conventional synthetic disease modifying anti-rheumatic drugs (DMARDs) and its performance is inferior to interferon gamma release assay (IGRA). Agreement between TST and IGRA is moderate to low. For hepatitis B virus (HBV): risk of reactivation is increased in patients positive for hepatitis B surface antigen. Anti-HBcore positive patients are at low risk for reactivation but should be monitored periodically with liver function tests and/or HBV-viral load. Risk for Hepatitis C reactivation is existing but low in patients treated with biological DMARDs. For Pneumocystis jirovecii , prophylaxis treatment should be considered in patients treated with prednisolone ≥15–30 mg/day for >2–4 weeks.

Conclusions : Different screening and prophylaxis approaches are described in the literature, partly determined by individual patient and disease characteristics.

Keywords

  • Antirheumatic Agents
  • Autoimmune Diseases
  • Therapeutics

Citation (ISO format)

FRAGOULIS, George E et al. Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. In: RMD open, 2022, vol. 8, n° 2, p. e002726. doi: 10.1136/rmdopen-2022-002726

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

2056-5933
17views
1126downloads

Technical informations

Creation

17/10/2024 11:28:23

First validation

10/12/2025 16:27:51

Update

10/12/2025 16:27:51

Status update

10/12/2025 16:27:51

Last indexation

10/12/2025 16:27:52
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated